Human Hematopoietic Stem Cell Engraftment and Differentiation in Immunodeficient Pigs
Xenotransplantation · 2025
DOI: 10.1111/xen.70077 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Xenotransplantation, 2025. Verfasst von Chen-Chen Pi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, The First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Transplantation, Heterologous, Hematopoietic Stem Cells, Cell Differentiation. Die Arbeit nennt 71 Literaturangaben. Gefördert von: Department of Science and Technology of Jilin Province, National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
Immunodeficient large animals that allow engraftment of human tissues and cells are highly valuable for translational studies. Recently, a strain of immunodeficient pigs (termed RGD pigs) was developed through the genetic inactivation of RAG1 , IL2RG , and CD47 . These RGD pigs lack functional T, B, and NK cells and do not exhibit CD47‐SIRPα incompatibility‐triggered macrophage xenoresponses. Transplantation of human hematopoietic stem/progenitor cells (HSPCs) into RGD pigs results in high levels of durable human hematopoietic engraftment and systemic repopulation with multilineage human lymphohematopoietic cells, including T, B, NK, and myeloid cells. The transplanted pigs maintain robust human hematopoiesis in the bone marrow (BM) and ongoing thymopoiesis in the thymus. Human T and B cells developing in these pigs express broad antigen receptor repertoires and exhibit tolerance to the recipient pig. The RGD pig is considered a valuable preclinical model for investigating normal or diseased human hematopoiesis and related therapies, and offers a potential bioreactor for large‐scale production of human immune cells. These pigs are also highly valuable for in vivo studies on other types of human tissues and cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, The First Hospital of Jilin University, Changchun, China.
- National-local Joint Engineering Laboratory of Animal Models For Human Diseases, Jilin University, Changchun, China.
- International Center of Future Science, Jilin University, Changchun, Jilin, China.
Förderung
- Department of Science and Technology of Jilin Province
- National Natural Science Foundation of China
- Ministry of Science and Technology of the People's Republic of China
- Strategic Priority Research Program of the Chinese Academy of Sciences
- Jilin Province Science and Technology Development Plan
- Bethune Medical Department of Jilin University
Zitieren
APA
Pi, C. C., Zou, J., Fang, M., Hu, Z., & Yang, Y. G. (2025). Human Hematopoietic Stem Cell Engraftment and Differentiation in Immunodeficient Pigs. Xenotransplantation. https://doi.org/10.1111/xen.70077
Vancouver
Pi CC, Zou J, Fang M, Hu Z, Yang YG. Human Hematopoietic Stem Cell Engraftment and Differentiation in Immunodeficient Pigs. Xenotransplantation. 2025. doi:10.1111/xen.70077
BibTeX
@article{Pi2025,
author = {Pi, Chen-Chen and Zou, Jun and Fang, Minghui and Hu, Zheng and Yang, Yong-Guang},
title = {Human Hematopoietic Stem Cell Engraftment and Differentiation in Immunodeficient Pigs},
journal = {Xenotransplantation},
year = {2025},
doi = {10.1111/xen.70077}
}
EUVIMED